Citius Oncology Cash Flow Statement (2023-2025) | CTOR

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -0.15M-0.20M-0.42M-4.73M-4.84M-4.77M-6.66M-7.74M-5.37M-5.00M-5.53M
Share-based Compensation (Quarter) 1.92M3.87M1.96M1.81M2.09M2.13M2.09M3.96M
Deferred Taxes (Quarter) 0.14M0.29M0.43M0.26M0.26M0.26M0.26M0.26M
Gains from Investment Securities (Quarter) 0.66M0.20M0.20M12.75M18.50M18.50M18.17M18.10M18.10M
Non-cash Items (Quarter) 3.94M14.39M5.14M9.91M5.39M5.56M
Cash from Operations (Quarter) -0.17M-0.10M-0.38M-0.19M-0.37M-7.35M
Change in Working Capital
Change in Receivables (Quarter) 4.05M
Change in Inventory (Quarter) 6.11M0.96M1.87M3.71M0.35M
Change in Account Payables (Quarter) -1.08M-0.79M11.45M2.31M1.66M2.91M2.65M1.98M
Change in Accured Expenses (Quarter) 0.02M0.07M0.36M-0.20M0.11M0.19M6.23M2.49M-0.26M-4.37M0.43M
Other Working Capital Changes (Quarter) 0.04M-0.03M-0.03M0.04M2.27M1.83M
Investing Activities
Change in Intangibles (Quarter) 4.40M
Cash from Investing Activities (Quarter) -0.66M24.74M0.07M-4.40M
Financing Activities
Cash from Financing Activities (Quarter) 0.78M-24.55M0.26M15.13M
Additional items
Change in Cash (Quarter) -0.17M0.25M-0.26M584.00-0.03M3.37M
Free Cash Flow (Quarter) -0.17M-0.10M-0.38M-0.19M-0.37M-7.35M
Net Cash Flow (Quarter) -0.17M-0.10M-0.26M584.00-0.03M3.37M